Phase III MARIANNE Study Fails To Improve PFS with Kadcyla in HER2-Positive Breast Cancer February 02, 2015Vol.38 No.01
Amgen Presents Phase II and III Vectibix Studies in Wild-Type RAS Colorectal Cancer February 02, 2015Vol.38 No.01
Two Phase III LUX-Lung Trials of Gilotrif Demonstrate Benefits in Overall Survival February 02, 2015Vol.38 No.01
Phase III Jakavi Trial in Polycythemia Vera Demonstrates Control Without Phlebotomy February 02, 2015Vol.38 No.01
Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up January 02, 2015Vol.37 No.12
Drugs & Targets FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza January 02, 2015Vol.37 No.12
